Saba Capital Discloses 24.94% Stake in Destra Multi-Alternative Fund
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Schedule 13D/A Amendment No. 12 discloses that Saba Capital Management, L.P., Saba Capital Management GP, LLC and Boaz R. Weinstein (together, the Reporting Persons) beneficially own 2,235,144 common shares of Destra Multi-Alternative Fund (ticker DMA), representing 24.94% of the 8,963,239 shares outstanding as of March 31, 2025. The Reporting Persons report shared voting and dispositive power over these shares and state approximately $15,109,969 was paid to acquire the reported position, funded from investor subscription proceeds, capital appreciation and margin borrowings. No new purpose for the holdings is reported and no contracts or arrangements concerning the securities are disclosed. Recent open-market transactions from the prior 8/18/25 filing through 9/9/25 are referenced and incorporated by Schedule A.
Positive
- Material stake disclosed: Reporting Persons beneficially own 2,235,144 shares, equal to 24.94% of DMA, a clearly material ownership level.
- Transparent funding disclosure: The filing states approximately $15,109,969 was paid and identifies sources (subscription proceeds, capital appreciation, margin).
- No adverse legal history disclosed: Reporting Persons state no relevant criminal convictions or disqualifying civil orders in the past five years.
Negative
- None.
Insights
TL;DR: Reporting Persons hold a substantial ~25% stake in DMA, a materially significant ownership level that could influence governance despite no stated activist intent.
The disclosed 24.94% beneficial ownership is large for a single reporting group and is material to DMA's capitalization. The filing confirms shared voting and dispositive power, and identifies ~$15.1 million deployed to build the position. While the filers state "Purpose of Transaction: Not Applicable," the presence of a near-25% stake typically warrants attention from investors and the board because such ownership can affect board composition, dividend policy and potential strategic outcomes even absent explicit demands. Absence of contractual arrangements or legal disclosures limits clarity on future intentions.
TL;DR: A sub-25% block owned with shared voting power is material and creates potential governance leverage without declared objectives.
The Schedule shows shared control rather than sole control, which suggests the stake is held within funds/accounts advised by Saba. No agreements or proposed actions are disclosed, so immediate governance changes are not asserted. Nonetheless, at nearly one quarter of the outstanding shares, the Reporting Persons occupy a position from which meaningful influence could be exercised in future proxy matters or board discussions. Investors should note the funding sources include margin borrowings, which can affect hold periods and disposition risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Saba Capital pay to acquire its DMA position?
Does the Schedule 13D/A state a purpose or intent for the stake in DMA?
AI-generated analysis. How Rhea-AI works. Not financial advice.